Hurst Photo / Shutterstock.com
Natco Pharma, an India-based drugs company, announced today that it has received final approval from the US Food and Drug Administration to produce a generic version of Tamiflu (oseltamivir phosphate).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Natco Pharma, FDA, ANDA, Tamiflu, oseltamivir phosphate, patent
